PH and glutathion-responsive hydrogel for localized delivery of paclitaxel

Colloids and Surfaces B: Biointerfaces

Volumn 116, Issue , 2014, Pages 247-256

  Pérez, Elena ^a   Fernández Olleros, Ana M ^a   Olmo, Rosa ^a   Teijón, Jose M ^a   Blanco, M Dolores ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cancer cells; Drug release; Nanohydrogels; Paclitaxel; Passive targeting; Stimuli responsive

Indexed keywords

ACRYLIC MONOMERS; AMIDES; CELL CULTURE; CELLS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; DYNAMIC LIGHT SCATTERING; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FREE RADICAL POLYMERIZATION; FREE RADICALS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGELS; LANTHANUM COMPOUNDS; MICROEMULSIONS; NANOSTRUCTURED MATERIALS; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; POLYETHYLENES;

CANCER CELLS; DRUG RELEASE; NANOHYDROGELS; PACLITAXEL; PASSIVE TARGETING; STIMULI-RESPONSIVE;

TARGETED DRUG DELIVERY;

ACRYLAMIDE DERIVATIVE; AMIDE; CARBAMIC ACID DERIVATIVE; FREE RADICAL; GLUTATHIONE; MONOMER; N HYDROXYETHYL ACRYLAMIDE; N,N' CYSTAMINEBISACRYLAMIDE; PACLITAXEL; POLY(N ISOPROPYLACRYLAMIDE); TERT BUTYL 2 ACRYLAMIDOETHYL CARBAMATE; UNCLASSIFIED DRUG; VINYL DERIVATIVE; ANTINEOPLASTIC AGENT; COUMARIN 6; COUMARIN DERIVATIVE; DRUG CARRIER; HYDROGEL; THIAZOLE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL TRANSPORT; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; FEMALE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MICROEMULSION; NANOENCAPSULATION; NANOHYDROGEL; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PLASMA; POLYMERIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS; SYNTHESIS; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; HELA CELL LINE; MCF 7 CELL LINE; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; GLUTATHIONE; HELA CELLS; HUMANS; HYDROGEL; HYDROGEN-ION CONCENTRATION; MCF-7 CELLS; PACLITAXEL; PARTICLE SIZE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; THIAZOLES;

EID: 84893381205     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.01.004     Document Type: Article

References (47)

1. Wichterle O., Bartl P., Rosenberg M. Nature 1960, 186:494-495.
2. Wichterle O., Lim D. Nature 1960, 185:117-118.
3. Blanco M.D., Olmo R., Teijón J. Encyclopedia of Pharmaceutical Technology 2002, Marcel Dekker, New York.
4. Chacko R., Ventura J., Zhuang J., Thayumanavan S. Adv. Drug Deliv. Rev. 2012, 64:836.
5. Kirschner C.M., Anseth K.S. Acta Mater. 2013, 61:931.
6. Sood N., Nagpal S., Nanda S., Bhardwaj A., Mehta A. J. Control Release 2013.
7. Gupta P., Vermani K., Garg S. Drug Discov. Today 2002, 569.
8. Ganta S., Devalapally H., Shahiwala A., Amiji M. J. Control Release 2008, 126:187.
9. Maeda H., Ueda M., Morinaga T., Matsumoto T. J. Med. Chem. 1985, 28:455.
10. Maeda H., Takeshita J., Kanamaru R. Int. J. Pept. Protein Res. 1979, 14:81.
11. Kwon J., Drumright R., Siegwart D., Matyjaszewski K. Prog. Polym. Sci. 2008, 33:448.
12. Oh J.K., Lee D.I., Park J.M. Prog. Polym. Sci. 2009, 34:1261.
13. Hoare T.R., Kohane D.S. Polymer 2008, 49:1993.
14. Raemdonck K., Demeester J., De Smedt S. Soft Matter 2009, 5:707.
15. Song N., Liu W.M., Tu Q., Liu R., Zhang Y.R., Wang J.Y. Colloids Surf. B 2011, 87:454.
16. Lehner R., Wang X.Y., Wolf M., Hunziker P. J. Control Release 2012, 161:307.
17. Qiao Z.Y., Zhang R., Du F.S., Liang D.H., Li Z.C. J. Control Release 2011, 152:57.
18. Hamidi M., Azadi A., Rafiei P. Adv. Drug Deliv. Rev. 2008, 60:1638.
19. Yallapu M.M., Jaggi M., Chauhan S.C. Drug Discov. Today 2011, 16:457.
20. Cheng R., Feng F., Meng F.H., Deng C., Feijen J., Zhong Z.Y. J. Control Release 2011, 152:2.
21. Spencer C.M., Faulds D. Drugs 1994, 48.
22. Dhanikula A.B., Panchagnula R. Int. J. Pharm. 1999, 183:85.
23. Weiss R.B., Donehower R.C., Wiernik P.H., Ohnuma T., Gralla R.J., Trump D.L., Baker J.R., Vanecho D.A., Vonhoff D.D., Leylandjones B. J. Clin. Oncol. 1990, 8:1263.
24. Marupudi N., Han J., Li K., Renard V., Tyler B., Brem H. Informa Healthcare 2007, 6.
25. Koutsopoulos S. Adv. Drug Deliv.Rev. 2012, 64:1459.
26. Sparreboom A., Scripture C.D., Trieu V., Williams P.J., De T., Yang A., Beals B., Figg W.D., Hawkins M., Desai N. Clinical Cancer Research 2005, 11:4136-4143.
27. Agüero L., Guerrero-Ramírez L., Katime I. Mater. Sci. Appl. 2010, 1:103.
28. Guerrero-Ramirez L.G., Nuno-Donlucas S.M., Cesteros L.C., Katime I. Mater. Chem. Phys. 2008, 112:1088.
29. Kim B.S., Kim C.S., Lee K.M. Arch. Pharm. Res. 2008, 31:1050.
30. Chawla J.S., Amiji M.M. Pharm. Int. J. 2002, 249.
31. Ahuja N., Katare O.P., Singh B. Eur. J. Pharm. Biopharm. 2007, 65:26.
32. Garcia-Fuentes M., Prego C., Torres D., Alonso M.J. Eur. J. Pharm. Sci. 2005, 25:133-143.
33. Han X., Liu J., Liu M., Xie C., Zhan C.Y., Gu B., Liu Y., Feng L.L., Lu W.Y. Int. J. Pharm. 2009, 372:125-131.
34. Park J.S., Han T.H., Lee K.Y., Han S.S., Hwang J.J., Moon D.H., Kim S.Y., Cho Y.W. J. Control Release 2006, 115:37.
35. Steichen S.D., Caldorera-Moore M., Peppas N.A. Eur. J. Pharm. Sci. 2013, 48:416.
36. Li Y., Wang J., Wientjes M., Au J. Adv. Drug Deliv. Rev. 2012, 64:29.
37. Moghimi S.M., Hunter A.C., Murray J.C. Pharmacol. Rev. 2001, 53:283-318.
38. Chithrani B.D., Chan W.C.W. Nano Lett. 2007, 7:1542.
39. Kumari A., Yadav S.K., Yadav S.C. Colloids Surf. B 2010, 75:1.
40. Nkansah M.K., Tzeng S.Y., Holdt A.M., Lavik E.B. Biotechnol. Bioeng. 2008, 100:1010.
41. Wang Y.P., Byrne J.D., Napier M.E., DeSimone J.M. Adv. Drug Deliv. Rev. 2012, 64:1021.
42. Paul D.R. Int. J. Pharm. 2011, 418:13.
43. Higuchi T. J. Pharm. Sci. 1963, 52:1145.
44. Brazel C.S., Peppas N.A. Eur. J. Pharm. Biopharm. 2000, 49:47.
45. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Int. J. Pharm. 1983, 15:25.
46. Ginnakakou P., Sackett D.L., Kang Y.-K. J. Biol. Chem. 1997, 272.
47. Qia L., Xu Z., Chenb M. Eur. J. Cancer 2007, 43:184.